Plasma Level of B-Type Natriuretic Peptide as a Prognostic Marker After Acute Myocardial Infarction - Concepedia

Concepedia

Publication | Closed Access

Plasma Level of B-Type Natriuretic Peptide as a Prognostic Marker After Acute Myocardial Infarction

140

Citations

36

References

2004

Year

Satoru Suzuki, Michihiro Yoshimura, Masafumi Nakayama, Yuji Mizuno, Eisaku Harada, Teruhiko Ito, Shota Nakamura, Kōji Abe, Megumi Yamamuro, Tomohiro Sakamoto,

Abstract

The plasma BNP level obtained 3 to 4 weeks after the onset of AMI can be used as an independent predictor of cardiac death in patients with AMI.

References

	Year	Citations
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients New England Journal of Medicine	2000	8.6K
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction Marc A. Pfeffer, Eugene Braunwald, Lemuel A. Moyé, New England Journal of Medicine	1992	5.9K
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction Bertram Pitt, Willem J. Remme, Faı̈ez Zannad, New England Journal of Medicine	2003	4.9K
A new natriuretic peptide in porcine brain Tetsuji Sudoh, Kenji Kangawa, Naoto Minamino, Nature NeurophysiologyNeuroanatomyPorcine BrainPhysiologyNeuropeptide Receptor	1988	1.8K
A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction Lars Køber, Christian Torp‐Pedersen, Jan E. Carlsen, New England Journal of Medicine	1995	1.8K
Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. Masashi Mukoyama, Kazuwa Nakao, Kiminori Hosoda, Journal of Clinical Investigation Predominant Bnp SynthesisHeart FailureCardiovascular FunctionDiastolic FunctionBnp Differ	1991	1.4K
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Hirofumi Yasue, Michihiro Yoshimura, Hayakazu Sumida, Circulation	1994	1.3K
The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes James A. de Lemos, David A. Morrow, Jane H. Bentley, New England Journal of Medicine	2001	1.3K
Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human J. C. Burnett, Pei-Chun Kao, D. C. Hu, Science HypertensionHeart FailureCardiomyopathyCardiovascular DiseaseAtherosclerosis	1986	888
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Inder S. Anand, Lloyd D. Fisher, YannTong Chiang, Circulation	2003	860

Page 1